Found: 75
Select item for more details and to access through your institution.
Treatment-Related Mortality With Everolimus in Cancer Patients.
- Published in:
- Oncologist, 2014, v. 19, n. 6, p. 661, doi. 10.1634/theoncologist.2013-0355
- By:
- Publication type:
- Article
Augmentation of Extracellular ATP Synergizes With Chemotherapy in Triple Negative Breast Cancer.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.855032
- By:
- Publication type:
- Article
Depression, Inflammation, and Intestinal Permeability: Associations with Subjective and Objective Cognitive Functioning throughout Breast Cancer Survivorship.
- Published in:
- Cancers, 2023, v. 15, n. 17, p. 4414, doi. 10.3390/cancers15174414
- By:
- Publication type:
- Article
Phase I Study of Veliparib on an Intermittent and Continuous Schedule in Combination with Carboplatin in Metastatic Breast Cancer: A Safety and [18F]‐Fluorothymidine Positron Emission Tomography Biomarker Study.
- Published in:
- Oncologist, 2020, v. 25, n. 8, p. e1158, doi. 10.1634/theoncologist.2020-0039
- By:
- Publication type:
- Article
Neoadjuvant Dual HER2-Targeted Therapy With Lapatinib and Trastuzumab Improves Pathologic Complete Response in Patients With Early Stage HER2-Positive Breast Cancer: A Meta-Analysis of Randomized Prospective Clinical Trials.
- Published in:
- Oncologist, 2015, v. 20, n. 4, p. 337, doi. 10.1634/theoncologist.2014-0334
- By:
- Publication type:
- Article
Effect of Metformin vs Placebo on Invasive Disease-Free Survival in Patients With Breast Cancer: The MA.32 Randomized Clinical Trial.
- Published in:
- JAMA: Journal of the American Medical Association, 2022, v. 327, n. 20, p. 1963, doi. 10.1001/jama.2022.6147
- By:
- Publication type:
- Article
BCR-Net: A deep learning framework to predict breast cancer recurrence from histopathology images.
- Published in:
- PLoS ONE, 2023, v. 17, n. 4, p. 1, doi. 10.1371/journal.pone.0283562
- By:
- Publication type:
- Article
A troubled heart: Mood disorder history longitudinally predicts faster cardiopulmonary aging in breast cancer survivorship.
- Published in:
- PLoS ONE, 2023, v. 17, n. 3, p. 1, doi. 10.1371/journal.pone.0283849
- By:
- Publication type:
- Article
Exploratory analysis of immune checkpoint receptor expression by circulating T cells and tumor specimens in patients receiving neo-adjuvant chemotherapy for operable breast cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Metastatic breast cancer patient perceptions of somatic tumor genomic testing.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Missing Components of Receptor Status Among Women With Invasive Breast Cancer.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 8, p. e2330791, doi. 10.1001/jamanetworkopen.2023.30791
- By:
- Publication type:
- Article
Worry and rumination in breast cancer patients: perseveration worsens self-rated health.
- Published in:
- Journal of Behavioral Medicine, 2021, v. 44, n. 2, p. 253, doi. 10.1007/s10865-020-00192-9
- By:
- Publication type:
- Article
Worry and Mindfulness Differentially Impact Symptom Burden Following Treatment Among Breast Cancer Survivors: Findings From a Randomized Crossover Trial.
- Published in:
- Annals of Behavioral Medicine, 2023, v. 57, n. 10, p. 888, doi. 10.1093/abm/kaad032
- By:
- Publication type:
- Article
Deep and Durable Response to Nivolumab and Temozolomide in Small-Cell Lung Cancer Associated With an Early Decrease in Myeloid-Derived Suppressor Cells.
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 4, p. e487, doi. 10.1016/j.cllc.2020.10.018
- By:
- Publication type:
- Article
PD‐L1 expression and CD8‐positive T cells are associated with favorable survival in HER2‐positive invasive breast cancer.
- Published in:
- Breast Journal, 2018, v. 24, n. 6, p. 911, doi. 10.1111/tbj.13112
- By:
- Publication type:
- Article
Phase Ib study of the combination of pexidartinib (PLX3397), a CSF-1R inhibitor, and paclitaxel in patients with advanced solid tumors.
- Published in:
- Therapeutic Advances in Medical Oncology, 2019, v. 11, p. 1, doi. 10.1177/1758835919854238
- By:
- Publication type:
- Article
Phase Ib study of the combination of pexidartinib (PLX3397), a CSF-1R inhibitor, and paclitaxel in patients with advanced solid tumors.
- Published in:
- Therapeutic Advances in Medical Oncology, 2019, v. 11, p. N.PAG, doi. 10.1177/1758835919854238
- By:
- Publication type:
- Article
Distress Disorder Histories Relate to Greater Physical Symptoms Among Breast Cancer Patients and Survivors: Findings Across the Cancer Trajectory.
- Published in:
- International Journal of Behavioral Medicine, 2023, v. 30, n. 4, p. 463, doi. 10.1007/s12529-022-10115-4
- By:
- Publication type:
- Article
Physical Activity After Breast Cancer Surgery: Does Depression Make Exercise Feel More Effortful than It Actually Is?
- Published in:
- International Journal of Behavioral Medicine, 2019, v. 26, n. 3, p. 237, doi. 10.1007/s12529-019-09778-3
- By:
- Publication type:
- Article
Palbociclib: A Novel Cyclin-Dependent Kinase Inhibitor for Hormone Receptor-Positive Advanced Breast Cancer.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Pathological complete response rates with pertuzumab-based neoadjuvant chemotherapy in breast cancer: A single-center experience.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 3, p. 572, doi. 10.1177/1078155219857800
- By:
- Publication type:
- Article
Updated report on incidence of infusion-site reactions associated with peripheral intravenous administration of fosaprepitant.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 5, p. 1053, doi. 10.1177/1078155218769347
- By:
- Publication type:
- Article
Making National Cancer Institute-Designated Comprehensive Cancer Center Knowledge Accessible to Community Oncologists via an Online Tumor Board: Longitudinal Observational Study.
- Published in:
- JMIR Cancer, 2022, v. 8, n. 2, p. 1, doi. 10.2196/33859
- By:
- Publication type:
- Article
The survival benefit of adjuvant trastuzumab with or without chemotherapy in the management of small (T1mic, T1a, T1b, T1c), node negative HER2+ breast cancer.
- Published in:
- NPJ Breast Cancer, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41523-024-00652-4
- By:
- Publication type:
- Article
A randomized phase 2 study of neoadjuvant carboplatin and paclitaxel with or without atezolizumab in triple negative breast cancer (TNBC) - NCI 10013.
- Published in:
- NPJ Breast Cancer, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41523-022-00500-3
- By:
- Publication type:
- Article
Heterogeneous atypical cell populations are present in blood of metastatic breast cancer patients.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Heterogeneous atypical cell populations are present in blood of metastatic breast cancer patients.
- Published in:
- Breast Cancer Research, 2014, v. 16, n. 2, p. 1, doi. 10.1186/bcr3622
- By:
- Publication type:
- Article
Phase 1 dose-escalation study evaluating the safety, pharmacokinetics, and clinical activity of OBI-3424 in patients with advanced or metastatic solid tumors.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 2, p. 266, doi. 10.1038/s41416-023-02280-4
- By:
- Publication type:
- Article
Phase 1 study of the ATR inhibitor berzosertib in combination with cisplatin in patients with advanced solid tumours.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Randomized placebo-controlled pilot trial of omega 3 fatty acids for prevention of aromatase inhibitor-induced musculoskeletal pain.
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 167, n. 3, p. 709, doi. 10.1007/s10549-017-4559-z
- By:
- Publication type:
- Article
Gait, balance, and patient-reported outcomes during taxane-based chemotherapy in early-stage breast cancer patients.
- Published in:
- Breast Cancer Research & Treatment, 2017, v. 164, n. 1, p. 69, doi. 10.1007/s10549-017-4230-8
- By:
- Publication type:
- Article
Myeloid-derived suppressor cells in breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2013, v. 140, n. 1, p. 13, doi. 10.1007/s10549-013-2618-7
- By:
- Publication type:
- Article
Specific kinesin expression profiles associated with taxane resistance in basal-like breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2012, v. 131, n. 3, p. 849, doi. 10.1007/s10549-011-1500-8
- By:
- Publication type:
- Article
Retrospective cohort study of CDK4/6-inhibitor-induced alopecia in breast cancer patients.
- Published in:
- Supportive Care in Cancer, 2023, v. 31, n. 12, p. 1, doi. 10.1007/s00520-023-08160-0
- By:
- Publication type:
- Article
The impact of granulocyte colony-stimulating factor use in patients with metastatic breast cancer treated with palliative chemotherapy: a single-institution retrospective review.
- Published in:
- Supportive Care in Cancer, 2020, v. 28, n. 11, p. 5537, doi. 10.1007/s00520-020-05392-2
- By:
- Publication type:
- Article
Fractional CO2 laser therapy for genitourinary syndrome of menopause for breast cancer survivors.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Circulating myeloid-derived suppressor cells increase in patients undergoing neo-adjuvant chemotherapy for breast cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 11, p. 1437, doi. 10.1007/s00262-017-2038-3
- By:
- Publication type:
- Article
Progression-Free Survival for Real-World Use of Palbociclib in Hormone Receptor-Positive Metastatic Breast Cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Effect of Immune Checkpoint Blockade on Myeloid-Derived Suppressor Cell Populations in Patients With Melanoma.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.740890
- By:
- Publication type:
- Article
Stopping paclitaxel premedication after two doses in patients not experiencing a previous infusion hypersensitivity reaction.
- Published in:
- Supportive Care in Cancer, 2015, v. 23, n. 7, p. 2019, doi. 10.1007/s00520-014-2556-x
- By:
- Publication type:
- Article
Incidence of infusion-site reactions associated with peripheral intravenous administration of fosaprepitant.
- Published in:
- Supportive Care in Cancer, 2014, v. 22, n. 6, p. 1461, doi. 10.1007/s00520-013-2106-y
- By:
- Publication type:
- Article
Docetaxel-induced skin toxicities in breast cancer patients subsequent to paclitaxel shortage: a case series and literature review.
- Published in:
- Supportive Care in Cancer, 2013, v. 21, n. 10, p. 2679, doi. 10.1007/s00520-013-1842-3
- By:
- Publication type:
- Article
Pilot study on the efficacy of an ondansetron- versus palonosetron-containing antiemetic regimen prior to highly emetogenic chemotherapy.
- Published in:
- Supportive Care in Cancer, 2013, v. 21, n. 10, p. 2845, doi. 10.1007/s00520-013-1865-9
- By:
- Publication type:
- Article
Clinical impact of interruption in adjuvant Trastuzumab therapy in patients with operable HER-2 positive breast cancer.
- Published in:
- Cardio-Oncology, 2020, v. 6, n. 1, p. N.PAG, doi. 10.1186/s40959-020-00081-9
- By:
- Publication type:
- Article
Living with Advanced Breast Cancer: A Descriptive Analysis of Survivorship Strategies.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 14, p. 3992, doi. 10.3390/jcm11143992
- By:
- Publication type:
- Article
Long-Term Follow-Up of Fractional CO 2 Laser Therapy for Genitourinary Syndrome of Menopause in Breast Cancer Survivors.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 3, p. 774, doi. 10.3390/jcm11030774
- By:
- Publication type:
- Article
Neoadjuvant therapy for breast cancer: Assessing treatment progress and managing poor responders.
- Published in:
- Current Oncology Reports, 2009, v. 11, n. 1, p. 37, doi. 10.1007/s11912-009-0007-5
- By:
- Publication type:
- Article
Phenoxodiol: Isoflavone analog with antineoplastic activity.
- Published in:
- Current Oncology Reports, 2006, v. 8, n. 2, p. 104, doi. 10.1007/s11912-006-0044-2
- By:
- Publication type:
- Article
LY3022855, an anti–colony stimulating factor-1 receptor (CSF-1R) monoclonal antibody, in patients with advanced solid tumors refractory to standard therapy: phase 1 dose-escalation trial.
- Published in:
- Investigational New Drugs, 2021, v. 39, n. 4, p. 1057, doi. 10.1007/s10637-021-01084-8
- By:
- Publication type:
- Article
Efficacy of different dosing schedules of capecitabine for metastatic breast cancer: a single-institution experience.
- Published in:
- Investigational New Drugs, 2020, v. 38, n. 5, p. 1605, doi. 10.1007/s10637-020-00891-9
- By:
- Publication type:
- Article